.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Deloitte
McKesson
Harvard Business School
Mallinckrodt
Dow
Julphar
Boehringer Ingelheim
Baxter
Chinese Patent Office

Generated: September 24, 2017

DrugPatentWatch Database Preview

HYDROXYZINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Hydroxyzine Hydrochloride, and when can generic versions of Hydroxyzine Hydrochloride launch?

Hydroxyzine Hydrochloride is a drug marketed by Vintage, Eci Pharms Llc, Elite Labs Inc, Hetero Labs Ltd Iii, Pharmafair, Luitpold, Amneal Pharm, Mutual Pharm, Solopak, Hi Tech Pharma, Ivax Pharms, Invagen Pharms, Hospira, Halsey, Pliva, Kv Pharm, Nuvo Pharm Inc, Purepac Pharm, Usl Pharma, Watson Labs, Fresenius Kabi Usa, Quantum Pharmics, Northstar Hlthcare, Sandoz, Baxter Hlthcare, Wyeth Ayerst, Able, Sun Pharm Inds, Actavis Elizabeth, Aurolife Pharma Llc, Altana, Silarx Pharms Inc, Prinston Inc, Mylan, Heritage Pharma, Sti Pharma Llc, Alpharma Us Pharms, Kvk Tech, Vintage Pharms, Smith And Nephew, Wockhardt, Superpharm, and Sun Pharm Inds Inc. and is included in one hundred and four NDAs.

The generic ingredient in HYDROXYZINE HYDROCHLORIDE is hydroxyzine hydrochloride. There are nineteen drug master file entries for this compound. Fifty-one suppliers are listed for this compound. Additional details are available on the hydroxyzine hydrochloride profile page.

Summary for Tradename: HYDROXYZINE HYDROCHLORIDE

Patents:0
Applicants:43
NDAs:104
Suppliers / Packagers: see list51
Bulk Api Vendors: see list103
Clinical Trials: see list2,295
Patent Applications: see list4,459
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:HYDROXYZINE HYDROCHLORIDE at DailyMed

Pharmacology for Tradename: HYDROXYZINE HYDROCHLORIDE

Drug ClassAntihistamine
Mechanism of ActionHistamine Receptor Antagonists
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pliva
HYDROXYZINE HYDROCHLORIDE
hydroxyzine hydrochloride
TABLET;ORAL081054-001Sep 25, 1995DISCNNoNo► Subscribe► Subscribe► Subscribe
Heritage Pharma
HYDROXYZINE HYDROCHLORIDE
hydroxyzine hydrochloride
TABLET;ORAL204279-002Aug 20, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Purepac Pharm
HYDROXYZINE HYDROCHLORIDE
hydroxyzine hydrochloride
TABLET;ORAL088121-001Sep 25, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
Pliva
HYDROXYZINE HYDROCHLORIDE
hydroxyzine hydrochloride
TABLET;ORAL088618-001Jan 10, 1986ABRXNoYes► Subscribe► Subscribe► Subscribe
Aurolife Pharma Llc
HYDROXYZINE HYDROCHLORIDE
hydroxyzine hydrochloride
TABLET;ORAL087871-001Dec 20, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Kvk Tech
HYDROXYZINE HYDROCHLORIDE
hydroxyzine hydrochloride
TABLET;ORAL040787-001Mar 20, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
HYDROXYZINE HYDROCHLORIDE
hydroxyzine hydrochloride
TABLET;ORAL086827-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Fresenius Kabi Usa
HYDROXYZINE HYDROCHLORIDE
hydroxyzine hydrochloride
INJECTABLE;INJECTION088185-001Mar 31, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
Sandoz
HYDROXYZINE HYDROCHLORIDE
hydroxyzine hydrochloride
TABLET;ORAL087245-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Nuvo Pharm Inc
HYDROXYZINE HYDROCHLORIDE
hydroxyzine hydrochloride
TABLET;ORAL207122-001Mar 29, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Mallinckrodt
Covington
Cerilliant
Express Scripts
US Army
Fish and Richardson
Daiichi Sankyo
Chubb
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot